Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients
- PMID: 31571775
- PMCID: PMC6761998
- DOI: 10.1016/j.jceh.2019.01.005
Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients
Abstract
Background & aims: Cirrhosis is a leading cause of morbidity and mortality in the United States. Early readmission to the hospital after discharge increases the clinical and economic burden of cirrhosis patients. We aim to evaluate the prevalence and predictors of early hospital readmission among cirrhosis patients among an underserved safety-net health system.
Methods: All consecutive adults with cirrhosis seen at the gastroenterology clinics at our safety-net health system from 2014 to 2016 were retrospectively evaluate to determine rates of 30-day readmission after hospital discharge. Comparison of readmission rates between groups used chi-square testing. Overall predictors of 30-day hospital readmission were evaluated using multivariate logistic regression models, with variables included in the model selected a priori based on clinical significance to the outcome.
Results: Among 230 cirrhosis patients (63.5% men, 80.6% were nonwhite minorities), 27.1% had chronic hepatitis C virus; 16.0%, chronic hepatitis B virus; 34.2%, alcoholic cirrhosis; and 8.0%, nonalcoholic steatohepatitis. Overall 30-day hospital readmission rates were 31.3%. There was a trend towards higher rates of 30-day readmission in men than in women (23.9% vs. 7.4%, P = 0.075) and trend towards higher readmission in Hispanics than in non-Hispanic whites (35.3% vs. 14.3%, P = 0.093). On multivariate regression, hepatic encephalopathy was the strongest positive predictor of early 30-day hospital readmission (odds ratio 4.40, 95% confidence interval 1.25-7.28, P = 0.02).
Conclusions: Among underserved safety-net cirrhosis patients, 30-day hospital readmission rates were over 30%. Given that presence of hepatic encephalopathy was most strongly correlated with readmissions, targeted interventions to improve management of hepatic encephalopathy may have the greatest impact on improving cirrhosis-related outcomes.
Keywords: HBV, hepatitis B virus; HCV, hepatitis C virus; ascites; cirrhosis; hepatic encephalopathy; hospitalization; safety-net.
© 2019 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
-
High Prevalence of Cirrhosis at Initial Presentation Among Safety-Net Adults with Chronic Hepatitis B Virus Infection.J Clin Exp Hepatol. 2018 Sep;8(3):235-240. doi: 10.1016/j.jceh.2017.11.009. Epub 2017 Nov 27. J Clin Exp Hepatol. 2018. PMID: 30302039 Free PMC article.
-
Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals.PLoS One. 2019 Mar 6;14(3):e0211811. doi: 10.1371/journal.pone.0211811. eCollection 2019. PLoS One. 2019. PMID: 30840670 Free PMC article.
-
Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.Dig Dis Sci. 2018 Sep;63(9):2267-2274. doi: 10.1007/s10620-018-4964-0. Epub 2018 Feb 19. Dig Dis Sci. 2018. PMID: 29457210 Free PMC article.
-
Preventing Readmissions of Hepatic Encephalopathy: Strategies in the Acute Inpatient, Immediate Postdischarge, and Longitudinal Outpatient Setting.Clin Liver Dis. 2024 May;28(2):359-367. doi: 10.1016/j.cld.2024.01.010. Epub 2024 Feb 12. Clin Liver Dis. 2024. PMID: 38548445 Review.
-
Hepatic encephalopathy and strategies to prevent readmission from inadequate transitions of care.J Hosp Med. 2022 Aug;17 Suppl 1:S17-S23. doi: 10.1002/jhm.12896. J Hosp Med. 2022. PMID: 35972038 Review.
Cited by
-
Care for Vulnerable Populations with Chronic Liver Disease: A Safety-Net Perspective.Healthcare (Basel). 2023 Oct 13;11(20):2725. doi: 10.3390/healthcare11202725. Healthcare (Basel). 2023. PMID: 37893800 Free PMC article. Review.
-
Remote monitoring of cognition in cirrhosis and encephalopathy: future opportunity and challenge.Metab Brain Dis. 2023 Jun;38(5):1737-1747. doi: 10.1007/s11011-022-01134-x. Epub 2022 Dec 12. Metab Brain Dis. 2023. PMID: 36507937 Free PMC article. Review.
-
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study.Front Med (Lausanne). 2023 May 25;10:1184860. doi: 10.3389/fmed.2023.1184860. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37305121 Free PMC article.
-
Hepatic Encephalopathy: From Metabolic to Neurodegenerative.Neurochem Res. 2021 Oct;46(10):2612-2625. doi: 10.1007/s11064-021-03372-4. Epub 2021 Jun 15. Neurochem Res. 2021. PMID: 34129161 Review.
References
-
- Scaglione S., Kliethermes S., Cao G. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol. 2015;49:690–696. - PubMed
-
- Statistics CfDCaPNCfH . 2018. Chronic Liver Disease and Cirrhosis.
-
- Scaglione S.J., Metcalfe L., Kliethermes S. Early hospital readmissions and mortality in patients with decompensated cirrhosis enrolled in a large national health insurance administrative database. J Clin Gastroenterol. 2017;51:839–844. - PubMed
LinkOut - more resources
Full Text Sources